BMS-986165
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for BMS-986165, covering 2016-12-28 to 2024-07-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis [Phase 2]